What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction
Projet mené par Patrick Verschueren (KU Leuven) : 'What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction'
Soutien
20.990 €
Restez informé.e des nouveaux individus ou organisations soutenus
